Progress in reducing cancer mortality in the United States by congressional district, 1996-2003 to 2012-2020.
breast cancer
colorectal cancer
congressional district
lung cancer
prostate cancer
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
15 08 2023
15 08 2023
Historique:
revised:
28
02
2023
received:
03
01
2023
accepted:
20
03
2023
medline:
23
10
2023
pubmed:
9
5
2023
entrez:
9
5
2023
Statut:
ppublish
Résumé
United States cancer death rates have been steadily declining since the early 1990s, but information on disparities in progress against cancer mortality across congressional districts is lacking. This study examined trends in cancer death rates, overall and for lung, colorectal, female breast, and prostate cancer by congressional district. County level cancer death counts and population data from the National Center for Health Statistics were used to estimate relative change in age-standardized cancer death rates from 1996-2003 to 2012-2020 by sex and congressional district. From 1996-2003 to 2012-2020, overall cancer death rates declined in every congressional district, with most congressional districts showing a 20%-45% decline among males and a 10%-40% decline among females. In general, the smallest percent of relative declines were found in the Midwest and Appalachia, whereas the largest declines were found in the South along the East Coast and the southern border. As a result, the highest cancer death rates generally shifted from congressional districts across the South in 1996-2003 to districts in the Midwest and central divisions of the South (including Appalachia) in 2012-2020. Death rates for lung, colorectal, female breast, and prostate cancers also declined in almost all congressional districts, although with some variation in relative changes and geographical patterns. Progress in reducing cancer death rates during the past 25 years considerably vary by congressional district, underscoring the need for strengthening existing and implementing new public health policies for broad and equitable application of proven interventions such as raising tax on tobacco and Medicaid expansion.
Sections du résumé
BACKGROUND
United States cancer death rates have been steadily declining since the early 1990s, but information on disparities in progress against cancer mortality across congressional districts is lacking. This study examined trends in cancer death rates, overall and for lung, colorectal, female breast, and prostate cancer by congressional district.
METHODS
County level cancer death counts and population data from the National Center for Health Statistics were used to estimate relative change in age-standardized cancer death rates from 1996-2003 to 2012-2020 by sex and congressional district.
RESULTS
From 1996-2003 to 2012-2020, overall cancer death rates declined in every congressional district, with most congressional districts showing a 20%-45% decline among males and a 10%-40% decline among females. In general, the smallest percent of relative declines were found in the Midwest and Appalachia, whereas the largest declines were found in the South along the East Coast and the southern border. As a result, the highest cancer death rates generally shifted from congressional districts across the South in 1996-2003 to districts in the Midwest and central divisions of the South (including Appalachia) in 2012-2020. Death rates for lung, colorectal, female breast, and prostate cancers also declined in almost all congressional districts, although with some variation in relative changes and geographical patterns.
CONCLUSIONS
Progress in reducing cancer death rates during the past 25 years considerably vary by congressional district, underscoring the need for strengthening existing and implementing new public health policies for broad and equitable application of proven interventions such as raising tax on tobacco and Medicaid expansion.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2522-2531Informations de copyright
© 2023 American Cancer Society.
Références
Ansolabehere S, Kuriwaki S. Congressional representation: accountability from the constituent's perspective. Am J Polit Sci. 2022;66(1):123-139. doi:10.1111/ajps.12607
Christensen D, Ejdemyr S. Do elections improve constituency responsiveness? Evidence from US cities. Polit Sci Res Methods. 2020;8(3):459-476. doi:10.1017/psrm.2018.46
Siegel RL, Sahar L, Portier KM, Ward EM, Jemal A. Cancer death rates in US congressional districts. CA Cancer J Clin. 2015;65(5):339-344. doi:10.3322/caac.21292
Senkomago V, Thompson TD, Scott LC, et al. Visualizing cancer incidence and mortality estimates by congressional districts, United States 2012-2016. J Registry Manag. 2020;47(2):67-79.
Islami F, Guerra CE, Minihan A, et al. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA Cancer J Clin. 2022;72(2):112-143. doi:10.3322/caac.21703
Centers for Disease Control and Prevention. Congressional district estimates. Estimated rate of cancer deaths in the United States, by congressional district, 2015-2019. Accessed August 8, 2022. https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/CongressionalDistricts
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33. doi:10.3322/caac.21708
Department of Health and Human Services. Protection of human research subjects, Subpart A, Section §46.102. Accessed October 7, 2021. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/revised-common-rule-regulatory-text/index.html
Census Bureau. 116th Congressional District wall maps. Accessed June 17, 2022. https://www.census.gov/geographies/reference-maps/2019/geo/cong-dist-116-wall.html
Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547-569. doi:10.1177/0962280206070621
Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688-701. doi:10.1177/1536867x1201200408
Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96-101. doi:10.1136/tobaccocontrol-2011-050294
He J, Zhu Z, Bundy JD, Dorans KS, Chen J, Hamm LL. Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018. JAMA. 2021;326(13):1286-1298. doi:10.1001/jama.2021.15187
Islami F, Ward EM, Sung H, et al. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics. J Natl Cancer Inst. 2021;113(12):1648-1669. doi:10.1093/jnci/djab131
Jemal A, Thun M, Yu XQ, et al. Changes in smoking prevalence among U.S. adults by state and region: estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007. BMC Publ Health. 2011;11(1):512. doi:10.1186/1471-2458-11-512
Centers for Disease Control and Prevention. Best practices for comprehensive tobacco control programs - 2014. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
Campaign for Tobacco-free Kids. State cigarette excise tax rates & rankings. Updated December 21, 2021. Accessed December 22, 2022. https://www.tobaccofreekids.org/assets/factsheets/0097.pdf
US Department of Health and Human Services. Smoking Cessation. A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
Khan LK, Sobush K, Keener D, et al. Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep. 2009;58(RR-7):1-26.
Centers for Disease Control and Prevention. Strategies to prevent obesity and other chronic diseases: the CDC guide to strategies to increase physical activity in the community. US Department of Health and Human Services; 2011.
Islami F, Goding Sauer A, Gapstur SM, Jemal A. Proportion of cancer cases attributable to excess body weight by US state, 2011-2015. JAMA Oncol. 2019;5(3):384-392. doi:10.1001/jamaoncol.2018.5639
Minihan AK, Patel AV, Flanders WD, Sauer AG, Jemal A, Islami F. Proportion of cancer cases attributable to physical inactivity by US state, 2013-2016. Med Sci Sports Exerc. 2022;54(3):417-423. doi:10.1249/mss.0000000000002801
Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-573. doi:10.1002/cncr.24760
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145-164. doi:10.3322/caac.21601
Hendrick RE, Helvie MA, Monticciolo DL. Breast cancer mortality rates have stopped declining in U.S. women younger than 40 years. Radiology. 2021;299(1):143-149. doi:10.1148/radiol.2021203476
Jatoi I, Sung H, Jemal A. The emergence of the racial disparity in U.S. breast-cancer mortality. N Engl J Med. 2022;386(25):2349-2352. doi:10.1056/nejmp2200244
DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438-451. doi:10.3322/caac.21583
Jemal A, Fedewa SA, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054-2061. doi:10.1001/jama.2015.14905
US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(3):185-191. doi:10.7326/0003-4819-149-3-200808050-00008
Moyer VA, US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134. doi:10.7326/0003-4819-157-2-201207170-00459
US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(18):1901-1913.
Fedewa SA, Bandi P, Smith RA, Silvestri GA, Jemal A. Lung cancer screening rates during the COVID-19 pandemic. Chest. 2022;161(2):586-589. doi:10.1016/j.chest.2021.07.030
Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409-436. doi:10.3322/caac.21731
Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640-649. doi:10.1056/nejmoa1916623
Sineshaw HM, Sahar L, Osarogiagbon RU, Flanders WD, Yabroff KR, Jemal A. County-level variations in receipt of surgery for early-stage non-small cell lung cancer in the United States. Chest. 2020;157(1):212-222. doi:10.1016/j.chest.2019.09.016
Bates JE, Parekh AD, Chowdhary M, Amdur RJ. Geographic distribution of radiation oncologists in the United States. Pract Radiat Oncol. 2020;10(6):e436-e443. doi:10.1016/j.prro.2020.04.008
Bates JE, Thaker NG, Parekh A, Royce TJ. Geographic access to brachytherapy services in the United States. Brachytherapy. 2022;21(1):29-32. doi:10.1016/j.brachy.2021.05.004
Kaiser Family Foundation. Status of state Medicaid expansion decisions: Interactive map. Accessed December 19, 2022. https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/
Kaiser Family Foundation. Five things to know about the renewal of extra Affordable Care Act subsidies in the Inflation Reduction Act. Accessed December 19, 2022. https://www.kff.org/policy-watch/five-things-to-know-about-renewal-of-extra-affordable-care-act-subsidies-in-inflation-reduction-act/
Wong FL, Miller JW. Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program: Increasing access to screening. J Womens Health (Larchmt). 2019;28(4):427-431. doi:10.1089/jwh.2019.7726
Sharma KP, DeGroff A, Hohl SD, et al. Multi-component interventions and change in screening rates in primary care clinics in the Colorectal Cancer Control Program. Prev Med Rep. 2022;29:101904. doi:10.1016/j.pmedr.2022.101904
Miller JW, Hanson V, Johnson GD, Royalty JE, Richardson LC. From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer. 2014;120(suppl 16):2549-2556. doi:10.1002/cncr.28823
Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31-46. doi:10.3322/caac.21586
Han X, Zhao J, Yabroff KR, Johnson CJ, Jemal A. Association between Medicaid expansion under the Affordable Care Act and survival among newly diagnosed cancer patients. J Natl Cancer Inst. 2022;114(8):1176-1185. doi:10.1093/jnci/djac077
Sturtevant L. The new District of Columbia: what population growth and demographic change mean for the city. J Urban Aff. 2014;36(2):276-299. doi:10.1111/juaf.12035
USAFacts. How has the population changed in Texas? 1990-2020. Accessed September 15, 2022. https://usafacts.org/data/topics/people-society/population-and-demographics/our-changing-population/state/texas?endDate=2020-01-01&startDate=1990-01-01